Self-compassion and Quality of Life After Dementia Diagnosis

April 13, 2026 updated by: Oxford Health NHS Foundation Trust

Is Self-compassion Associated With Older Adults' Quality of Life After Dementia Diagnosis and Does Perceived Threat Posed by Dementia Mediate This Relationship?

This study aims to investigate whether self-compassion is associated with older adult's quality of life after a diagnosis of dementia, and whether perceived threat posed by dementia mediates this relationship. Self-compassion has been found to be positive in supporting individuals in times of difficulty, in adjustment processes and older adults' wellbeing. While different factors have begun to be identified which are associated with individuals' psychological wellbeing and adjustment following a dementia diagnosis, little is known about the influence of self-compassion.

Participants will be recruited via NHS memory clinics, Join Dementia Research and from the community via third-sector organisations. Individuals will be invited to attend a Microsoft Teams/telephone appointment in which informed consent and cognitive screening processes will take place at the start. Eligible participants will then be invited to continue to complete measures administered by a researcher and an interview question. Participants will be offered the opportunity to complete the measures in a second session (within 8 weeks) or using the online survey software, Qualtrics, if preferred.

A small pilot study (n = 5) will take place prior to the main study.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 7JX
        • Oxford Health NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The participant sample is anticipated to comprise NHS patients who have been seen in memory clinic and individuals recruited from the community.

Description

Inclusion Criteria:

  • An older adult aged ≥ 65 years
  • A confirmed diagnosis of dementia received within the past 12 months
  • They have knowledge of their diagnosis
  • They have English language proficiency
  • They have capacity to give informed consent to participation.

Exclusion Criteria:

  • They are deemed to lack capacity to give informed consent to participate (as per the Mental Capacity Act, 2005).
  • They have a diagnosis of early-onset dementia, defined as individuals who are aged < 65 at diagnosis
  • A score on the MoCA Blind (Nasreddine, 2022b) screening measure of <7 out of 22, which is calculated as equivalent to <10 out of 30 on the MoCA (Nasreddine et al., 2005).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
'High self-compassion' group
Participants' total mean score on the Self-compassion Scale - Short Form will be used as the independent variable. A median split (+/-1 standard error of the median) on the Self-compassion Scale - Short Form will be used to retrospectively allocate participants to groups, with participants scoring ≥ + 1 standard error of the median on the Self-compassion Scale - Short Form allocated to a 'High self-compassion' group.
'Low self-compassion' group
Participants' total mean score on the Self-compassion Scale - Short Form will be used as the independent variable. A median split (+/-1 standard error of the median) on the Self-compassion Scale - Short Form will be used to retrospectively allocate participants to groups, with participants scoring ≤ - 1 standard error of the median on the Self-compassion Scale - Short Form allocated to a 'Low self-compassion' group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life in Alzheimer's Disease
Time Frame: Through study completion, average 40-60 minutes
The Quality of Life in Alzheimer's Disease consists of 13 items relating to different aspects of quality of life, such as mood, physical health, friends and ability to do things for fun. Each item is scored from 1 ('poor') to 4 ('excellent') to calculate a total score.
Through study completion, average 40-60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress Appraisal Measure
Time Frame: Through study completion, average 40-60 minutes
The Stress Appraisal Measure consists of 28 items pertaining to perceived future threat, measured across seven subscales; three referring to primary appraisals of threat, centrality and challenge, three relating to secondary appraisal - controllable by self, controllable by others and uncontrollable), and stressfulness. Only the threat and 'stressfulness' subscales, consisting of four items respectively, will be completed.
Through study completion, average 40-60 minutes
Geriatric Depression Scale - 10
Time Frame: Through study completion, average 40-60 minutes
The Geriatric Depression Scale - 10, consisting of 10 items relating to how the person has felt over the past week (e.g. 'do you feel happy most of the time?'), has good reliability (α = 0.75), sensitivity and specificity. The Geriatric Depression Scale -10 is considered a reliable screening measure for major depression in older adults.
Through study completion, average 40-60 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-compassion Scale - Short Form
Time Frame: Through study completion, average 40-60 minutes
The Self-Compassion Scale - Short Form consists of 12 items relating to six subscales (self-judgement, self-kindness, common humanity, mindfulness, isolation and over-identification), with each item scored from 1 ('almost never') to 5 ('almost always') and three items reverse-scored. The Self-Compassion Scale - Short Form is a shortened version of the Self-Compassion Scale. It is recommended utilising a total mean score calculated using the subscale mean scores, and this will be adopted in the current study to form the independent variable.
Through study completion, average 40-60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2024

Primary Completion (Actual)

October 23, 2024

Study Completion (Actual)

October 23, 2024

Study Registration Dates

First Submitted

May 24, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 18, 2024

Study Record Updates

Last Update Posted (Actual)

April 16, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Subscribe